BPC-157 and TB-500, pre-blended in a single lyophilized vial, 20mg total. BPC-157 (Body Protection Compound) is a pentadecapeptide first isolated from human gastric juice and studied in soft tissue and gut integrity research. TB-500 is a synthetic fragment of Thymosin Beta-4, studied in cell migration and tissue remodeling research. One vial, not a kit. Powder only. For research use only. Not for human consumption.
- What it is: A blend of two separate research peptides, BPC-157 and TB-500, combined in one vial.
- Researchers have studied the components for: tendon and ligament repair (BPC-157), wound closure and cell migration (TB-500), and new blood vessel growth during healing (both).
- Evidence level: Mostly preclinical animal work, plus a few small human trials of the natural protein behind TB-500. No published study tested this combined blend itself.
- The short version: This is two separately studied compounds sitting in one vial for research convenience. Almost all of the work is in animal models, with a little early human data on Thymosin Beta-4, the protein TB-500 is built from. The two get put together because researchers often study them in the same tissue-repair setting, not because any study showed the pair works better than either one alone.


